3D-microenvironments initiate TCF4 expression rescuing nuclear β-catenin activity in MCF-7 breast cancer cells
Source abstract
Abstract
Mechanical cues sensed by tumor cells in their microenvironment can influence important mechanisms including adhesion, invasion and proliferation. However, a common mechanosensitive protein and/or pathway can be regulated in different ways among diverse types of tumors. Of particular interest are human breast epithelial cancers, which markedly exhibit a heterogeneous pattern of nuclear β-catenin localization, a protein known to be involved in both mechanotransduction and tumorigenesis. β-catenin can be aberrantly accumulated in the nucleus wherein it binds to and activates lymphoid enhancer factor/T cell factor (LEF/TCF) transcription factors. At present, little is known about how mechanical cues are integrated into breast cancer cells harboring impaired mechanisms of β-catenin's nuclear uptake and/or retention. This prompted us to investigate the influence of mechanical cues on MCF-7 human breast cancer cells which are known to fail in relocating β-catenin into the nucleus due to very low baseline levels of LEF/TCFs. Exploiting three-dimensional (3D) microscaffolds realized by two-photon lithography, we show that surrounding MCF-7 cells have not only a nuclear pool of β-catenin, but also rescue from their defective expression of TCF4 and boost invasiveness. Together with heightened amounts of vimentin, a β-catenin/TCF-target gene regulator of proliferation and invasiveness, such 3D-elicited changes indicate an epithelial-to-mesenchymal phenotypic switch of MCF-7 cells. This is also consistent with an increased in situ MCF-7 cell proliferation that can be abrogated by blocking β-catenin/TCF-transcription activity. Collectively, these data suggest that 3D microenvironments are per se sufficient to prime a TCF4-dependent rescuing of β-catenin nuclear activity in MCF-7 cells. The employed methodology could, therefore, provide a mechanism-based rationale to dissect further aspects of mechanotranscription in breast cancerogenesis, somewhat independent of β-catenin's nuclear accumulation. More importantly, by considering the heterogeneity of β-catenin signaling pathway in breast cancer patients, these data may open alternative avenues for personalized disease management and prevention. STATEMENT OF SIGNIFICANCE: Mechanical cues play a critical role in cancer pathogenesis. Little is known about their influence in breast cancer cells harboring impaired mechanisms of β-catenin's nuclear uptake and/or retention, involved in both mechanotransduction and tumorigenesis. We engineered 3D scaffold, by two-photon lithography, to study the influence of mechanical cues on MCF-7 cells which are known to fail in relocating β-catenin into the nucleus. We found that 3D microenvironments are per se sufficient to prime a TCF4-dependent rescuing of β-catenin nuclear activity that boost cell proliferation and invasiveness. Thus, let us suggest that our system could provide a mechanism-based rationale to further dissect key aspects of mechanotranscription in breast cancerogenesis and progression, somewhat independent of β-catenin's nuclear accumulation.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Cellular Mechanics and Interactions · Wnt/β-catenin signaling in development and cancer · Cell Adhesion Molecules Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (72)
Show source-provided references
1. A tense situation: forcing tumour progression10.1038/nrc2544 ↗
2. The mechanical microenvironment in cancer: how physics affects tumours10.1016/j.semcancer.2015.09.001 ↗
3. Physico-mechanical aspects of extracellular matrix influences on tumorigenic behaviors10.1016/j.semcancer.2010.04.004 ↗
4. Tumor mechanosensing and its therapeutic potential10.1002/jcb.26786 ↗
5. Gene expression perturbation in vitro—A growing case for three-dimensional (3D) culture systems10.1016/j.semcancer.2005.06.009 ↗
6. Taking cell-matrix adhesions to the third dimension10.1126/science.1064829 ↗
7. Capturing complex 3D tissue physiology in vitro10.1038/nrm1858 ↗
8. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer10.1146/annurev.cellbio.22.010305.104315 ↗
9. Breakdown of cell-collagen networks through collagen remodeling
10. The microenvironment determines the breast cancer cells' phenotype: organization of MCF7 cells in 3D cultures10.1186/1471-2407-10-263 ↗
11. Tumor cell migration in complex microenvironments10.1007/s00018-012-1115-1 ↗
12. Engineering 3D approaches to model the dynamic microenvironments of cancer bone metastasis10.1038/s41413-018-0008-9 ↗
13. Application of synthetic polymeric scaffolds in breast cancer 3D tissue cultures and animal tumor models10.1155/2017/8074890 ↗
14. Physical limits of cell migration: control by ecm space and nuclear deformation and tuning by proteolysis and traction force10.1083/jcb.201210152 ↗
15. Plasticity of cell migration: a multiscale tuning model10.1083/jcb.200909003 ↗
16. Collagen fiber array of peritumoral stroma influences epithelial-to-mesenchymal transition and invasive potential of mammary cancer cells10.3390/jcm8020213 ↗
17. Tunable mechanical properties of stent-like microscaffolds for studying cancer cell recognition of stiffness gradients10.1016/j.mee.2018.01.007 ↗
18. Studying cell mechanobiology in 3D: the two-photon lithography approach
19. Microenvironmental stiffness of 3D polymeric structures to study invasive rates of cancer cells10.1002/adhm.201700888 ↗
20. Three-dimensional cage-like microscaffolds for cell invasion studies10.1038/srep10531 ↗
21. The many faces and functions of β‐catenin10.1038/emboj.2012.150 ↗
22. Decisions, decisions: β-catenin chooses between adhesion and transcription10.1016/j.tcb.2005.03.002 ↗
23. Convergence of wnt, ß-Catenin, and cadherin pathways10.1126/science.1094291 ↗
24. The β-Catenin axis integrates multiple signals downstream from RET/Papillary thyroid carcinoma leading to cell proliferation10.1158/0008-5472.CAN-08-1982 ↗
25. Phosphorylation and free pool of β-Catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration10.1074/jbc.274.15.10173 ↗
26. Regulation of β-Catenin structure and activity by tyrosine phosphorylation10.1074/jbc.M100194200 ↗
27. BCR‐ABL stabilizes β‐catenin in chronic myeloid leukemia through its tyrosine phosphorylation10.1038/sj.emboj.7601485 ↗
28. β-catenin and its regulatory network10.1016/j.humpath.2005.02.002 ↗
29. Nucleo-cytoplasmic distribution of β-catenin is regulated by retention10.1242/jcs.02864 ↗
30. Regulation of β-Catenin nuclear dynamics by GSK-3β involves a LEF-1 positive feedback loop10.1111/j.1600-0854.2011.01207.x ↗
31. Wnt signaling through inhibition of β-Catenin degradation in an intact axin1 complex10.1016/j.cell.2012.05.002 ↗
32. Factors affecting the nuclear localization of β-Catenin in normal and malignant tissue10.1002/jcb.24803 ↗
33. Characterization of a beta-catenin nuclear localization defect in MCF-7 breast cancer cells10.1016/j.yexcr.2016.01.020 ↗
34. Expression patterns of β-catenin in in situ and invasive breast cancer10.1053/ejso.1999.1017 ↗
35. Targeting WNT signaling in colorectal cancer. a review in the theme: cell signaling: proteins, pathways and mechanisms10.1152/ajpcell.00117.2015 ↗
36. Role of WNT/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance10.2147/JHC.S156701 ↗
37. β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation10.1038/modpathol.2010.205 ↗
38. Cytoplasmic localization of β-Catenin is a marker of poor outcome in breast cancer patients10.1158/1055-9965.EPI-09-0741 ↗
39. Evolutionary conservation of early mesoderm specification by mechanotransduction in Bilateria10.1038/ncomms3821 ↗
40. A tense situation: forcing Tumour progression10.1038/nrc2544 ↗
41. Actomyosin-Mediated cellular tension drives increased tissue stiffness and β-Catenin activation to induce epidermal hyperplasia and tumor growth10.1016/j.ccr.2011.05.008 ↗
42. Nanopatterned polymer substrates promote endothelial proliferation by initiation of β-catenin transcriptional signaling10.1016/j.actbio.2012.04.018 ↗
43. Mechanical properties of β-Catenin revealed by single-molecule experiments10.1016/j.bpj.2012.07.051 ↗
44. Mechanical factors activate ß‐catenin‐dependent oncogene expression in APC1638N/+ mouse colon10.2976/1.2955566 ↗
45. Mechanical properties tunability of three-dimensional polymeric structures in two-photon lithography
46. Wnt–β-catenin–Tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer10.1038/bjc.2011.269 ↗
47. Restricted high level expression of tcf-4 protein in intestinal and mammary gland epithelium10.1016/S0002-9440(10)65247-9 ↗
48. Mechanisms of tumor cell extravasation in an in vitro microvascular network platform10.1039/c3ib40149a ↗
49. Cadherin-11 is expressed in invasive breast cancer cell lines
50. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression10.1073/pnas.060025397 ↗
51. FH535 inhibits proliferation and migration of colorectal cancer cells by regulating Cyclina2 and claudin1 gene expression
52. FH535 inhibited migration and growth of breast cancer cells10.1371/journal.pone.0044418 ↗
53. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling10.1083/jcb.200102028 ↗
54. Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myeloma10.1073/pnas.0610299104 ↗
55. Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic WNT signaling10.1126/scitranslmed.3003808 ↗
56. The regulation of β-catenin activity and function in cancer: therapeutic opportunities10.18632/oncotarget.15687 ↗
57. A small-molecule inhibitor of TCF/β-catenin signaling down-regulates PPARγ and PPARδ activities10.1158/1535-7163.MCT-07-2063 ↗
58. Homophilic adhesion of E-cadherin occurs by a co-operative two-step interaction of N-terminal domains10.1002/j.1460-2075.1996.tb00719.x ↗
59. Adhesion signaling: how β-catenin interacts with its partners10.1016/S0960-9822(01)00473-0 ↗
60. β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis10.1093/carcin/bgq269 ↗
61. LEF-1 drives aberrant β-catenin nuclear localization in myeloid leukemia cells
62. Tumor-induced solid stress activates β-catenin signaling to drive malignant behavior in normal, tumor-adjacent cells, Bioessays: news and reviews in molecular
63. WNT signalling and haematopoiesis: a WNT–WNT situation10.1038/nri1529 ↗
64. Wnt/β-Catenin signaling and disease10.1016/j.cell.2012.05.012 ↗
65. Regulation of transcription factors by protein degradation10.1007/PL00000760 ↗
66. Tissue mechanics modulate microRNA-dependent pten expression to regulate malignant progression10.1038/nm.3497 ↗
67. Molecular and cellular biology of intermediate filaments10.1146/annurev.bi.57.070188.003113 ↗
68. Transactivation of vimentin by β-Catenin in human breast cancer cells
69. VImentin expression in cervical carcinomas: association with invasive and migratory potential10.1002/(SICI)1096-9896(199610)180:2<175::AID-PATH630>3.0.CO;2-G ↗
70. Vimentin contributes to human mammary epithelial cell migration10.1242/jcs.112.24.4615 ↗
71. The epithelial-to-mesenchymal transition in cancer10.3390/cancers10020052 ↗
72. Translating epithelial mesenchymal transition markers into the clinic: novel insights from proteomics10.1016/j.euprot.2016.01.003 ↗